La Jolla, CA, United States of America

Kyle S Jones

This inventor holds 15 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Immunotherapy Proteins. Top assignees: Inhibrx, Inc., Inhibex, Inc.. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyle S Jones. Retrieved from https://idiyas.com/inventor/kyle-s-jones

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 86(Granted Patents)


Location History:

  • La Jolla, CA (US) (2015 - 2023)
  • San Marcos, CA (US) (2017 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
OX40-binding Polypeptides
DR5-binding Fusion Proteins
CD123-binding Polypeptides
PDL1-binding Proteins
CD33-binding Polypeptides
GITR-binding Antibodies
41BB-binding Fusion Proteins
CD47 Antibodies
Multivalent Proteins
Multispecific Antibodies
Immune Modulation
Cancer Treatment
15 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Kyle S. Jones

Introduction: Kyle S. Jones is a prominent inventor based in La Jolla, California. With an impressive portfolio of 15 patents, he has made significant contributions to the field of biomedicine. His inventions focus on innovative biological approaches, particularly in immune modulation.

Latest Patents: Among Kyle's latest patents is his work on "OX40-binding polypeptides and uses thereof." This invention presents VHH-containing polypeptides that bind and activate OX40, offering potential therapeutic uses. Another noteworthy patent involves "Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells." This disclosure introduces molecules that engage death receptor 5 (DR5), which is crucial for immune cell modulation, showcasing his impactful contributions to immunology.

Career Highlights: Kyle S. Jones has established himself in the biotechnology sector through his roles in various companies. Notably, he has worked with Inhibrx, Inc. and Inhibex, Inc., where he has advanced his research initiatives and patent contributions.

Collaborations: Throughout his career, Kyle has collaborated with esteemed colleagues, including Brendan P. Eckelman and John C. Timmer. These partnerships have been instrumental in fostering innovation and driving forward the development of his novel inventions.

Conclusion: Kyle S. Jones's inventive spirit and dedication to scientific advancement are evident in his numerous patents and professional collaborations. His ongoing work in the field of immune modulation holds promise for future therapeutic developments, marking him as a significant figure in contemporary biomedical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…